Issue 24 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

21

No.

24

June 16, 1995Jun 16, 1995

Free

DOWNLOAD THE PDF

Cooperative Groups Advised To Plan For Future Of Less Funding from NCI

In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow

ODAC Recommends Ethyol, DaunoXome For FDA Approval

ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation

Cancer Panel Urges Improved Funding For Basic Science

FDA, NIH Streamline Approvals For Gene Therapy Studies

Report Criticizes NIH Grant Review

NIH Policy On Diversity In Sponsored Meetings

Recent Issues

Volume 52 | Issue 16 - April 24, 2026

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026

Volume 52 | Issue 11 - March 20, 2026